Invagen Pharms Company Profile
✉ Email this page to a colleague
What is the competitive landscape for INVAGEN PHARMS, and what generic and branded alternatives to INVAGEN PHARMS drugs are available?
INVAGEN PHARMS has sixty-one approved drugs.
There is one tentative approval on INVAGEN PHARMS drugs.
Drugs and US Patents for Invagen Pharms
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Invagen Pharms | CYCLOBENZAPRINE HYDROCHLORIDE | cyclobenzaprine hydrochloride | TABLET;ORAL | 090478-002 | Jul 23, 2010 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Invagen Pharms | AMLODIPINE BESYLATE | amlodipine besylate | TABLET;ORAL | 206367-003 | Dec 10, 2015 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Invagen Pharms | FOSINOPRIL SODIUM | fosinopril sodium | TABLET;ORAL | 077222-003 | Apr 20, 2005 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Invagen Pharms | VIGABATRIN | vigabatrin | FOR SOLUTION;ORAL | 211592-001 | Dec 3, 2019 | AA | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Invagen Pharms
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Invagen Pharms | LEUPROLIDE ACETATE FOR DEPOT SUSPENSION | leuprolide acetate | FOR SUSPENSION;INTRAMUSCULAR | 205054-001 | Aug 28, 2018 | 9,789,064 | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.